SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies touches roof on the BSE

22 Nov 2018 Evaluate

Indoco Remedies is locked at upper circuit limit at Rs. 206.40, up by 34.40 points or 20.00% from its previous closing of Rs. 172.00 on the BSE.

The scrip opened at Rs. 172.05 and has touched a high and low of Rs. 206.40 and Rs. 167.05 respectively. So far 57721 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 317.00 on 24-Jan-2018 and a 52 week low of Rs. 150.25 on 08-Oct-2018.

Last one week high and low of the scrip stood at Rs. 206.40 and Rs. 159.25 respectively. The current market cap of the company is Rs. 1901.98 crore.

The promoters holding in the company stood at 58.87%, while Institutions and Non-Institutions held 14.97% and 26.16% respectively.

US Food and Drug Administration (USFDA) has inspected Indoco Remedies’ Sterile facility (Plant II) and Solid Dosages facility (Plant III) situated at Goa from November 14 to 21, 2018. The inspection concluded with Indoco receiving 2 minor observations, none of which are repeat in nature.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

228.20 -23.05 (-9.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×